EUVIMEDObjevte EUVIMED
Crossref

Biosimilar medical products: What a physician needs to know

The Internet Journal of Family Practice · 2010

DOI: 10.5580/194a ↗

At a glance

Journal article in The Internet Journal of Family Practice, 2010. Cited 1 times so far (Crossref).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

The first generation of approved biopharmaceuticals was developed a few decades ago. Drugs such as insulin, growth hormone, erythroprotein and cytokines were manufactured using recombinant DNA (rDNA) technology or hybridoma methods. They have improved the lives of countless patients of diabetes, short stature, anaemia, cancer, multiple sclerosis and hepatitis. Patents for many of these firstgeneration biotechnology products have, or are soon going to, expire. In many parts of world , strict patent laws are not in force. This has led to the development of various ‘copies” of these molecules by drug manufacturers. These products are known as biosimilars.

Cite

APA

(2010). Biosimilar medical products: What a physician needs to know. The Internet Journal of Family Practice. https://doi.org/10.5580/194a

Vancouver

Biosimilar medical products: What a physician needs to know. The Internet Journal of Family Practice. 2010. doi:10.5580/194a

BibTeX
@article{euvimed2010,
  title = {Biosimilar medical products: What a physician needs to know},
  journal = {The Internet Journal of Family Practice},
  year = {2010},
  doi = {10.5580/194a}
}
Start for free →